These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The team and the prescription]. Brunissen MF Soins Psychiatr; 1989; (106-107):47. PubMed ID: 2603000 [No Abstract] [Full Text] [Related]
6. [Treatment of psychiatric emergencies with a new neuroleptic drug: sultopride]. Planche R Sem Hop Ther; 1976 Apr; 52(4):261-2. PubMed ID: 948771 [No Abstract] [Full Text] [Related]
7. [Sultopride: a new powerful neuroleptic (author's transl)]. Anglade P; Baraer J Sem Hop; 1979 Jan 8-15; 55(1-2):63-7. PubMed ID: 34217 [TBL] [Abstract][Full Text] [Related]
8. [Trial therapy of psychomotor disorder with a new neuroleptic, sultopride]. Coulon P Brux Med; 1979 May; 59(5):275-7. PubMed ID: 466540 [No Abstract] [Full Text] [Related]
9. [Long-term dogmatil therapy in major psychiatry]. Szymonowicz R Sem Hop; 1983 May; 59(19):1468-70. PubMed ID: 6310763 [TBL] [Abstract][Full Text] [Related]
10. [Solian: evaluation of 10 years' experimentation and clinical practice]. Baldauf A; Metzger JY; Sichel JP Ann Med Psychol (Paris); 1988; 146(1-2):63-6. PubMed ID: 2901244 [No Abstract] [Full Text] [Related]
11. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine. Jagadheesan K; Muirhead D Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830 [No Abstract] [Full Text] [Related]
12. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report. Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977 [No Abstract] [Full Text] [Related]